{"product_id":"diagnostic-imaging-breast-hardback-9780323548120","title":"Diagnostic Imaging: Breast (Hardback) 9780323548120","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Imaging: Breast\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThousands of clinical images and meticulously updated content keep you current in breast imaging\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eWendie A. Berg (Author), Jessica Leung (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323548120, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 5 September 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1350 pages, 4300 illustrations (4300 in full color)\u003cbr\u003e28.1 x 22.2 x 5.9 cm, 3.99 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eCovering the entire spectrum of this fast-changing field, \u003ci\u003eDiagnostic Imaging: Breast\u003c\/i\u003e, third edition,\u003ci\u003e \u003c\/i\u003eis an invaluable resource not only for radiologists, but for all health care professionals involved in the management of breast disease. From \u003cb\u003escreening and diagnostic mammography and tomosynthesis, ultrasound, and MR to contrast-enhanced mammography and molecular imaging,\u003c\/b\u003e Drs. Wendie Berg and Jessica Leung, along with their expert author team, provide carefully updated information in a concise, bulleted format. Thousands of high-quality illustrations highlight \u003cb\u003enot only image acquisition and interpretation\u003c\/b\u003e, but also \u003cb\u003escreening guidelines,\u003c\/b\u003e \u003cb\u003ebreast anatomy, genetic testing, image-guided procedures, determining the extent of disease and much more\u003c\/b\u003e. This book provides essential, clinically-focused details for everyday breast imaging.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eFeatures \u003cb\u003emore than 4,000 annotated, updated images throughout\u003c\/b\u003e, including imaging findings complemented by histopathologic and clinical correlates of the spectrum of breast disease\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003etimely coverage of less common but important topics\u003c\/b\u003e such as gender reassignment, disease-causing mutations and risk assessment, malignancy in pregnancy, nodal disease in breast cancer care, and male breast disease\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiscusses \u003cb\u003enew technologies\u003c\/b\u003e, including abbreviated MR, contrast-enhanced mammography, and automated breast ultrasound\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes updated information on \u003cb\u003eevolving medical, oncologic, surgical, and radiation, and oncoplastic treatment of the breast cancer patient\u003c\/b\u003e, along with discussion of ongoing trials and future directions\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOffers \u003cb\u003eexpanded and updated information\u003c\/b\u003e on dense breast reporting, screening recommendations, patients at elevated risk, and imaging paradigms in patients with dense breasts, as well as analysis of various updated breast cancer screening guidelines\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eUses \u003cb\u003ebulleted, succinct text\u003c\/b\u003e for fast and easy comprehension of essential information\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eEnhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eAnatomy and Normal Variants \u003c\/p\u003e \u003cp\u003eAnatomy \u003c\/p\u003e \u003cp\u003eBreast Overview\u003c\/p\u003e \u003cp\u003eEmbryology and Normal Development\u003c\/p\u003e \u003cp\u003eNipple-Areolar Complex and Skin\u003c\/p\u003e \u003cp\u003eSegmental Anatomy\u003c\/p\u003e \u003cp\u003ePectoralis Muscle and Chest Wall\u003c\/p\u003e \u003cp\u003eNeurovascular Supply\u003c\/p\u003e \u003cp\u003eLymph Nodes and Lymphatics\u003c\/p\u003e \u003cp\u003eAxilla\u003c\/p\u003e \u003cp\u003eNormal Variants \u003c\/p\u003e \u003cp\u003eAxillary Breast Tissue\u003c\/p\u003e \u003cp\u003ePectoralis Muscle and Chest Wall Variants\u003c\/p\u003e \u003cp\u003eSternalis Muscle\u003c\/p\u003e \u003cp\u003eImaging \u003c\/p\u003e \u003cp\u003eModalities \u003c\/p\u003e \u003cp\u003eMammography: Positioning\u003c\/p\u003e \u003cp\u003eMammography: Diagnostic\u003c\/p\u003e \u003cp\u003eTomosynthesis\u003c\/p\u003e \u003cp\u003eContrast-Enhanced Mammography\/Tomosynthesis\u003c\/p\u003e \u003cp\u003eUltrasound\u003c\/p\u003e \u003cp\u003eElastography\u003c\/p\u003e \u003cp\u003eAutomated Breast Ultrasound\u003c\/p\u003e \u003cp\u003eMagnetic Resonance Imaging\u003c\/p\u003e \u003cp\u003eDiffusion-Weighted Imaging (MR)\u003c\/p\u003e \u003cp\u003eMR Spectroscopy\u003c\/p\u003e \u003cp\u003eMolecular Breast Imaging (MBI and BSGI)\u003c\/p\u003e \u003cp\u003eDedicated Breast PET (PEM)\u003c\/p\u003e \u003cp\u003ePET\/CT\u003c\/p\u003e \u003cp\u003eInterpretive Criteria \u003c\/p\u003e \u003cp\u003eApproach to the Lexicons of Breast Imaging\u003c\/p\u003e \u003cp\u003eMammography BI-RADS Lexicon and Usage\u003c\/p\u003e \u003cp\u003eUltrasound BI-RADS Lexicon and Usage\u003c\/p\u003e \u003cp\u003eMR BI-RADS Lexicon and Usage\u003c\/p\u003e \u003cp\u003eProbably Benign Lesions\u003c\/p\u003e \u003cp\u003eMolecular Breast Imaging Lexicon (Includes BSGI)\u003c\/p\u003e \u003cp\u003eBreast PET Lexicon and Usage\u003c\/p\u003e \u003cp\u003eLesion Imaging Characteristics \u003c\/p\u003e \u003cp\u003eMasses \u003c\/p\u003e \u003cp\u003eCircumscribed and Obscured Margins\u003c\/p\u003e \u003cp\u003eIntramammary Lymph Node\u003c\/p\u003e \u003cp\u003eFat-Containing Mass\u003c\/p\u003e \u003cp\u003eMicrolobulated Margins\u003c\/p\u003e \u003cp\u003eIndistinct Margins\u003c\/p\u003e \u003cp\u003eSpiculated Margins\u003c\/p\u003e \u003cp\u003eHigh-Density Mass\u003c\/p\u003e \u003cp\u003eCalcifications, Typically Benign \u003c\/p\u003e \u003cp\u003eTypically Benign Calcifications\u003c\/p\u003e \u003cp\u003eRound Calcifications\u003c\/p\u003e \u003cp\u003eMilk of Calcium\u003c\/p\u003e \u003cp\u003eCalcifications, Not Typically Benign \u003c\/p\u003e \u003cp\u003ePunctate Calcifications\u003c\/p\u003e \u003cp\u003eCoarse Heterogeneous Calcifications\u003c\/p\u003e \u003cp\u003eAmorphous Calcifications\u003c\/p\u003e \u003cp\u003eFine Pleomorphic Calcifications\u003c\/p\u003e \u003cp\u003eFine Linear Calcifications\u003c\/p\u003e \u003cp\u003eCalcification Distribution \u003c\/p\u003e \u003cp\u003eDiffuse Distribution of Calcifications\u003c\/p\u003e \u003cp\u003eRegional Distribution of Calcifications\u003c\/p\u003e \u003cp\u003eGrouped Distribution of Calcifications\u003c\/p\u003e \u003cp\u003eLinear Distribution of Calcifications\u003c\/p\u003e \u003cp\u003eSegmental Distribution of Calcifications\u003c\/p\u003e \u003cp\u003eAdditional Findings \u003c\/p\u003e \u003cp\u003eOne-View-Only Findings\u003c\/p\u003e \u003cp\u003eAsymmetries\u003c\/p\u003e \u003cp\u003eDeveloping Asymmetry\u003c\/p\u003e \u003cp\u003eArchitectural Distortion\u003c\/p\u003e \u003cp\u003eTrabecular Thickening, Edema\u003c\/p\u003e \u003cp\u003eMultiple Bilateral Similar Findings\u003c\/p\u003e \u003cp\u003eDuct Ectasia\u003c\/p\u003e \u003cp\u003eSolitary Dilated Duct\u003c\/p\u003e \u003cp\u003eUltrasound Lesion Characteristics \u003c\/p\u003e \u003cp\u003eMargins, Not Circumscribed (US)\u003c\/p\u003e \u003cp\u003eEchogenic Rim (US)\u003c\/p\u003e \u003cp\u003eLesion Orientation (US)\u003c\/p\u003e \u003cp\u003ePosterior Acoustic Features: Enhancement \u0026amp; Shadowing (US)\u003c\/p\u003e \u003cp\u003ePosterior Shadowing (US)\u003c\/p\u003e \u003cp\u003eEchogenicity: Anechoic (US)\u003c\/p\u003e \u003cp\u003eEchogenicity: Isoechoic, Hypoechoic, and Mixed (US)\u003c\/p\u003e \u003cp\u003eEchogenicity: Hyperechoic (US)\u003c\/p\u003e \u003cp\u003eHeterogeneous Internal Echogenicity (US)\u003c\/p\u003e \u003cp\u003eSimple Cyst (US)\u003c\/p\u003e \u003cp\u003eComplicated Cyst With Debris (US)\u003c\/p\u003e \u003cp\u003eClustered Microcysts (US)\u003c\/p\u003e \u003cp\u003eIntraductal Mass (US)\u003c\/p\u003e \u003cp\u003eComplex Cystic and Solid Masses\u003c\/p\u003e \u003cp\u003eCalcifications (US)\u003c\/p\u003e \u003cp\u003eMR Findings \u003c\/p\u003e \u003cp\u003eBackground Parenchymal Enhancement (MR)\u003c\/p\u003e \u003cp\u003eT2 Hyperintensity (MR)\u003c\/p\u003e \u003cp\u003eKinetic Assessment (MR)\u003c\/p\u003e \u003cp\u003eDark Internal Septations (MR)\u003c\/p\u003e \u003cp\u003eRim Enhancement (MR)\u003c\/p\u003e \u003cp\u003eFocus (MR)\u003c\/p\u003e \u003cp\u003eFocal Area, Regional, and Diffuse Enhancement (MR)\u003c\/p\u003e \u003cp\u003eLinear Enhancement (MR)\u003c\/p\u003e \u003cp\u003eSegmental Enhancement (MR) \u003c\/p\u003e \u003cp\u003eClumped and Clustered Ring Enhancement (MR)\u003c\/p\u003e \u003cp\u003eClustered Ring Enhancement (MR) [DELETE AFTER WENDIE DONE WITH IT]\u003c\/p\u003e \u003cp\u003eHistopathologic Diagnoses \u003c\/p\u003e \u003cp\u003eApproach to Histopathologic Diagnoses \u003c\/p\u003e \u003cp\u003eBenign Lesions \u003c\/p\u003e \u003cp\u003eTubular Adenoma and Nipple Adenoma\u003c\/p\u003e \u003cp\u003eAdenosis, Sclerosing Adenosis, Microglandular Adenosis\u003c\/p\u003e \u003cp\u003eApocrine Metaplasia\u003c\/p\u003e \u003cp\u003eColumnar Cell Lesions\u003c\/p\u003e \u003cp\u003eCyst, Ruptured\/Inflamed\u003c\/p\u003e \u003cp\u003eFat Necrosis, Oil Cyst\u003c\/p\u003e \u003cp\u003eHamartoma (Fibroadenolipoma)\u003c\/p\u003e \u003cp\u003eFibroadenoma\u003c\/p\u003e \u003cp\u003eFibroadenomatoid Change\u003c\/p\u003e \u003cp\u003eFibrocystic Changes\u003c\/p\u003e \u003cp\u003eFibrosis\u003c\/p\u003e \u003cp\u003eHematoma\u003c\/p\u003e \u003cp\u003eLipoma and Angiolipoma\u003c\/p\u003e \u003cp\u003eMyoepithelial Neoplasms\u003c\/p\u003e \u003cp\u003eMyofibroblastoma\u003c\/p\u003e \u003cp\u003ePapilloma, Benign\u003c\/p\u003e \u003cp\u003ePASH\u003c\/p\u003e \u003cp\u003eRisk Lesions \u003c\/p\u003e \u003cp\u003eRadial Scar, Radial Sclerosing Lesions\u003c\/p\u003e \u003cp\u003eAtypical Ductal Hyperplasia\u003c\/p\u003e \u003cp\u003eAtypical Lobular Hyperplasia\u003c\/p\u003e \u003cp\u003eFlat Epithelial Atypia\u003c\/p\u003e \u003cp\u003eLobular Carcinoma In Situ (Classic)\u003c\/p\u003e \u003cp\u003eMucocele-Like Lesions\u003c\/p\u003e \u003cp\u003eAtypical Papilloma\u003c\/p\u003e \u003cp\u003eLocally Aggressive Lesions \u003c\/p\u003e \u003cp\u003eFibromatosis\u003c\/p\u003e \u003cp\u003eGranular Cell Tumor\u003c\/p\u003e \u003cp\u003ePhyllodes Tumor: Benign\u003c\/p\u003e \u003cp\u003eMalignant Lesions \u003c\/p\u003e \u003cp\u003eDCIS, General\u003c\/p\u003e \u003cp\u003eDCIS, Low Grade\u003c\/p\u003e \u003cp\u003eDCIS, Intermediate Grade\u003c\/p\u003e \u003cp\u003eDCIS, High Grade\u003c\/p\u003e \u003cp\u003eDCIS, Micropapillary\u003c\/p\u003e \u003cp\u003eInvasive Ductal Carcinoma NOS, General\u003c\/p\u003e \u003cp\u003eInvasive Ductal Carcinoma NOS, Grade 1, 2, 3\u003c\/p\u003e \u003cp\u003eInvasive Lobular Carcinoma\u003c\/p\u003e \u003cp\u003eInvasive Lobular Carcinoma, Pleomorphic\u003c\/p\u003e \u003cp\u003eLobular Carcinoma In Situ, Pleomorphic\u003c\/p\u003e \u003cp\u003eMixed Invasive Ductal and Lobular Carcinoma\u003c\/p\u003e \u003cp\u003eApocrine Carcinoma\u003c\/p\u003e \u003cp\u003eInvasive Micropapillary Carcinoma\u003c\/p\u003e \u003cp\u003eLuminal A and B Cancers\u003c\/p\u003e \u003cp\u003eHER2-Positive Cancer\u003c\/p\u003e \u003cp\u003eTriple-Negative and Basal-Like Breast Cancer\u003c\/p\u003e \u003cp\u003eAdenoid Cystic Carcinoma\u003c\/p\u003e \u003cp\u003eMedullary Carcinoma\u003c\/p\u003e \u003cp\u003eMetaplastic Carcinoma\u003c\/p\u003e \u003cp\u003eMucinous Carcinoma\u003c\/p\u003e \u003cp\u003eTubular Carcinoma\u003c\/p\u003e \u003cp\u003eTubulolobular Carcinoma\u003c\/p\u003e \u003cp\u003eEncapsulated Papillary Carcinoma\u003c\/p\u003e \u003cp\u003ePapillary Carcinoma, Invasive\u003c\/p\u003e \u003cp\u003ePhyllodes Tumor: Borderline and Malignant\u003c\/p\u003e \u003cp\u003eSarcomas\u003c\/p\u003e \u003cp\u003eLymphoma, Primary Breast\u003c\/p\u003e \u003cp\u003eSigns and Symptoms \u003c\/p\u003e \u003cp\u003eApproach to Signs and Symptoms of Disease \u003c\/p\u003e \u003cp\u003eNipple \u003c\/p\u003e \u003cp\u003eNipple Discharge\u003c\/p\u003e \u003cp\u003eNipple Retraction and Inversion\u003c\/p\u003e \u003cp\u003ePaget Disease of the Nipple\u003c\/p\u003e \u003cp\u003eSkin \u003c\/p\u003e \u003cp\u003eEpidermoid Cyst\u003c\/p\u003e \u003cp\u003eSebaceous Cyst\u003c\/p\u003e \u003cp\u003eSkin Lesions, Other\u003c\/p\u003e \u003cp\u003eErythema\u003c\/p\u003e \u003cp\u003eSkin Retraction\u003c\/p\u003e \u003cp\u003eSkin Thickening\u003c\/p\u003e \u003cp\u003eAxilla \u003c\/p\u003e \u003cp\u003eAxillary Adenopathy\u003c\/p\u003e \u003cp\u003eAxillary Nodal Calcification\u003c\/p\u003e \u003cp\u003eMetastatic Adenopathy, Unknown Primary\u003c\/p\u003e \u003cp\u003eBreast \u003c\/p\u003e \u003cp\u003ePalpable Lump or Thickening\u003c\/p\u003e \u003cp\u003ePain\u003c\/p\u003e \u003cp\u003eShrunken Breast\u003c\/p\u003e \u003cp\u003eVascular Entities \u003c\/p\u003e \u003cp\u003eMondor Disease\u003c\/p\u003e \u003cp\u003eBenign Lesions of Vascular Origin\u003c\/p\u003e \u003cp\u003ePostoperative and Post-Treatment Imaging \u003c\/p\u003e \u003cp\u003eApproach to Postoperative Imaging Findings \u003c\/p\u003e \u003cp\u003eResults of Benign Intervention \u003c\/p\u003e \u003cp\u003eBenign Surgical Biopsy, Postoperative Imaging\u003c\/p\u003e \u003cp\u003ePost-Core Biopsy and Clip Placement Imaging\u003c\/p\u003e \u003cp\u003eReduction Mammoplasty, Imaging\u003c\/p\u003e \u003cp\u003eImplant, Saline\u003c\/p\u003e \u003cp\u003eImplant, Silicone\u003c\/p\u003e \u003cp\u003eImplant With Multiple Lumina\u003c\/p\u003e \u003cp\u003eImplants and Cancer\u003c\/p\u003e \u003cp\u003eSilicone Granuloma\u003c\/p\u003e \u003cp\u003eCosmetic Augmentation Injections\u003c\/p\u003e \u003cp\u003eResults Following Treatment for Malignancies \u003c\/p\u003e \u003cp\u003ePositive or Close Margins\u003c\/p\u003e \u003cp\u003ePost Breast-Conserving Surgery\u003c\/p\u003e \u003cp\u003eRecurrent Breast Carcinoma\u003c\/p\u003e \u003cp\u003eNeoadjuvant Chemotherapy\u003c\/p\u003e \u003cp\u003eAccelerated Partial Breast Irradiation\u003c\/p\u003e \u003cp\u003eTissue Transfer Reconstruction Imaging\u003c\/p\u003e \u003cp\u003eSpecial Topics \u003c\/p\u003e \u003cp\u003eHormonal Changes \u003c\/p\u003e \u003cp\u003eHormonal Manipulation \u003c\/p\u003e \u003cp\u003eGender Reassignment \u003c\/p\u003e \u003cp\u003eTerminology and Imaging Appearance\u003c\/p\u003e \u003cp\u003eCancer and Screening in Transgendered Patients\u003c\/p\u003e \u003cp\u003ePregnancy \u003c\/p\u003e \u003cp\u003eGalactocele\u003c\/p\u003e \u003cp\u003eLactation\u003c\/p\u003e \u003cp\u003eLactating Adenoma\u003c\/p\u003e \u003cp\u003ePregnancy-Associated Breast Cancer\u003c\/p\u003e \u003cp\u003eInfections and Inflammation \u003c\/p\u003e \u003cp\u003eAbscess\u003c\/p\u003e \u003cp\u003eIdiopathic Granulomatous Mastitis \u003c\/p\u003e \u003cp\u003eMastitis\u003c\/p\u003e \u003cp\u003eUnusual Infections\u003c\/p\u003e \u003cp\u003eBreast Manifestations of Systemic Conditions \u003c\/p\u003e \u003cp\u003eWeight Fluctuations\u003c\/p\u003e \u003cp\u003eDiabetic Mastopathy\/Lymphocytic Lobulitis\u003c\/p\u003e \u003cp\u003eCollagen Vascular Disease\u003c\/p\u003e \u003cp\u003eBreast Manifestations of Organ Failure\u003c\/p\u003e \u003cp\u003eSarcoid\u003c\/p\u003e \u003cp\u003eAmyloid\u003c\/p\u003e \u003cp\u003eLeukemia\u003c\/p\u003e \u003cp\u003eLymphoma, Secondary\u003c\/p\u003e \u003cp\u003eMetastases to Breast\u003c\/p\u003e \u003cp\u003eTrauma \u003c\/p\u003e \u003cp\u003eTrauma\u003c\/p\u003e \u003cp\u003eMale Breast \u003c\/p\u003e \u003cp\u003eGynecomastia\u003c\/p\u003e \u003cp\u003eMale, Breast Cancer\u003c\/p\u003e \u003cp\u003eMale, Other Neoplasms\u003c\/p\u003e \u003cp\u003eArtifacts \u003c\/p\u003e \u003cp\u003eArtifacts: Mammography and Tomosynthesis\u003c\/p\u003e \u003cp\u003eArtifacts: Ultrasound\u003c\/p\u003e \u003cp\u003eArtifacts: MR\u003c\/p\u003e \u003cp\u003eArtifacts: Nuclear Medicine\u003c\/p\u003e \u003cp\u003eImaging Safety \u003c\/p\u003e \u003cp\u003eRadiation Dose and Safety: Mammography and Tomosynthesis\u003c\/p\u003e \u003cp\u003eGadolinium Safety\u003c\/p\u003e \u003cp\u003eContrast Reactions\u003c\/p\u003e \u003cp\u003eScreening \u003c\/p\u003e \u003cp\u003eFocused Issues in Screening \u003c\/p\u003e \u003cp\u003eApproach to Screening\u003c\/p\u003e \u003cp\u003eRisk Assessment Models\u003c\/p\u003e \u003cp\u003eScreening Mammography\u003c\/p\u003e \u003cp\u003eScreening Intervals: Annual vs. Biennial\u003c\/p\u003e \u003cp\u003eScreening at Age Extremes (\u0026lt; 40, \u0026gt; 70 Years)\u003c\/p\u003e \u003cp\u003eScreening in 5th Decade (40-49 Years)\u003c\/p\u003e \u003cp\u003eInterval Cancers\u003c\/p\u003e \u003cp\u003eMissed Cancers\u003c\/p\u003e \u003cp\u003eCAD and Double Reading\u003c\/p\u003e \u003cp\u003eBreast Density\u003c\/p\u003e \u003cp\u003eScreening Ultrasound\u003c\/p\u003e \u003cp\u003eScreening MR\u003c\/p\u003e \u003cp\u003eAbbreviated Breast MR\u003c\/p\u003e \u003cp\u003ePersonal History of Breast Cancer Surveillance\u003c\/p\u003e \u003cp\u003ePrior Chest Radiation Therapy, Surveillance\u003c\/p\u003e \u003cp\u003eGenetics \u003c\/p\u003e \u003cp\u003eIndications for Genetic Testing\u003c\/p\u003e \u003cp\u003eBRCA1 and BRCA2 Mutation Carriers\u003c\/p\u003e \u003cp\u003eLi-Fraumeni Syndrome\u003c\/p\u003e \u003cp\u003eGene Mutations Beyond BRCA\u003c\/p\u003e \u003cp\u003eGenetic Testing Techniques (e.g., Oncotype, MammoPrint)\u003c\/p\u003e \u003cp\u003eTreatment \u003c\/p\u003e \u003cp\u003ePrinciples in Treatment \u003c\/p\u003e \u003cp\u003eApproach to Breast Cancer\u003c\/p\u003e \u003cp\u003eStaging: Breast\u003c\/p\u003e \u003cp\u003ePathology Overview\u003c\/p\u003e \u003cp\u003eSurgery Overview\u003c\/p\u003e \u003cp\u003eRadiation Therapy Overview\u003c\/p\u003e \u003cp\u003eOncology Overview (Adjuvant and Neoadjuvant)\u003c\/p\u003e \u003cp\u003eFocused Issues in Treatment \u003c\/p\u003e \u003cp\u003eApproach to Treatment Planning\u003c\/p\u003e \u003cp\u003eMultifocal\/Multicentric Breast Cancer\u003c\/p\u003e \u003cp\u003eExtensive Intraductal Component\u003c\/p\u003e \u003cp\u003eContralateral Breast Cancer\u003c\/p\u003e \u003cp\u003eLocally Advanced Breast Cancer\u003c\/p\u003e \u003cp\u003ePectoralis Muscle and Chest Wall Invasion\u003c\/p\u003e \u003cp\u003eSkin Invasion\u003c\/p\u003e \u003cp\u003eInflammatory Breast Carcinoma\u003c\/p\u003e \u003cp\u003eInternal Mammary Adenopathy\u003c\/p\u003e \u003cp\u003eMetastatic Breast Cancer\u003c\/p\u003e \u003cp\u003eBreast Cancer in Young Patients (\u0026lt; 40 Years)\u003c\/p\u003e \u003cp\u003eProcedures \u003c\/p\u003e \u003cp\u003eImage-Guided Procedures \u003c\/p\u003e \u003cp\u003eDuctography\u003c\/p\u003e \u003cp\u003eCyst Aspiration\u003c\/p\u003e \u003cp\u003eFine-Needle Aspiration Biopsy, Breast\u003c\/p\u003e \u003cp\u003eSkin Localization\u003c\/p\u003e \u003cp\u003eUltrasound-Guided Core Biopsy\u003c\/p\u003e \u003cp\u003eUltrasound-Guided Vaccum-Assisted Biopsy\u003c\/p\u003e \u003cp\u003eStereotactic Biopsy, Prone\u003c\/p\u003e \u003cp\u003eStereotactic Biopsy, Upright\u003c\/p\u003e \u003cp\u003eMR-Guided Vacuum-Assisted Biopsy\u003c\/p\u003e \u003cp\u003eMR-Directed Ultrasound\u003c\/p\u003e \u003cp\u003eImaging-Histopathologic Discordance\u003c\/p\u003e \u003cp\u003ePreoperative Wire Localization, Mammography\u003c\/p\u003e \u003cp\u003ePreoperative Wire Localization, Ultrasound\u003c\/p\u003e \u003cp\u003ePreoperative Wire Localization, MR\u003c\/p\u003e \u003cp\u003ePreoperative Localization, Tomosynthesis\u003c\/p\u003e \u003cp\u003ePreoperative Radioactive Seed Localization\u003c\/p\u003e \u003cp\u003ePreoperative Localization in Axilla\u003c\/p\u003e \u003cp\u003ePreoperative Lesion Localization, Bracketing\u003c\/p\u003e \u003cp\u003ePreoperative Magnetic, Other Nonradioactive Localization\u003c\/p\u003e \u003cp\u003eSpecimen Imaging\u003c\/p\u003e \u003cp\u003eImage-Guided Thermal Ablation (and Cryotherapy)\u003c\/p\u003e \u003cp\u003eSurgical Procedures \u003c\/p\u003e \u003cp\u003eSentinel Lymph Node Biopsy\u003c\/p\u003e \u003cp\u003eAxillary Lymph Node Dissection\u003c\/p\u003e \u003cp\u003eTargeted Axillary Dissection\u003c\/p\u003e \u003cp\u003eBreast-Conserving Surgery\u003c\/p\u003e \u003cp\u003eMastectomy\u003c\/p\u003e \u003cp\u003eOncoplastic Techniques\u003c\/p\u003e \u003cp\u003eReduction Mammoplasty, Procedure\u003c\/p\u003e \u003cp\u003eTRAM and Other Flap Procedures\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Radiology [\u003ca title=\"See our other books on Radiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Radiology%20%5BMMPH%5D%22\"\u003eMMPH\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648375705880,"sku":"9780323548120","price":224.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323548120_c60a629a-72fe-4e3b-9a92-259eea25da80.jpg?v=1694989933","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/diagnostic-imaging-breast-hardback-9780323548120","provider":"Freshly Printed Books","version":"1.0","type":"link"}